Angelini
Angelini is a medium-sized private international group. Founded in Italy in the early twentieth century, the Angelini group has offices in 25 countries. Led by President Francesco Angelini, the industrial group employs approximately 3000 people.[1]
 | |
| Type | Private |
|---|---|
| Industry | Pharma, Personal care, Machinery, Wine, Perfumery |
| Founded | 1919 |
| Headquarters | Rome, Italy |
Area served | Worldwide |
Key people | Francesco Angelini |
| Revenue | Approx. 1.4 Billion Euro (2013) |
Number of employees | Approx. 3000 (2021) |
| Website | www.angelinipharma.com |
The antidepressant medication Trazodone was developed in the 1960s by scientists at Angelini.[2]
In a 2018 evaluation of firms' reputation issued by Reputation Institute, Angelini ranked 66th in general and second among life sciences companies.[3]
In 2020, Angelini took over ownership of Thermacare after Pfizer spun off the transdermal analgesic patch after its merger with GlaxoSmithKline's consumer healthcare division.
References
- Who We Are - Angelini
- Gorecki, Dennis K.J.; Verbeeck, Roger K. (1987). "Trazondone Hydrochloride". In Forey, Klaus (ed.). Profiles of Drug Substances, Excipients and Related Methodology Vol. 16. Academic Press. p. 695. ISBN 9780080861111.
- https://www.aboutpharma.com/blog/2018/04/19/reputazione-aziendale-ecco-le-migliori-150-societa-in-italia-il-pharma-arranca/ Redazione Aboutpharma Online. 19 April 2018. Retrieved 7 May 2018. (in Italian)
External links
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.